Importantly, the Msi2-reporter mouse we developed may be valuable not only for identifying LSCs but for a broader range of aggressive cancers with highly upregulated Msi2 expression, such as hepatocellular carcinoma, glioblastoma and breast cancer18,41. The gene discussed is MSI2; the disease is cancer.